发明名称 CYCLOPROPANE COMPOUND
摘要 <p>A cyclopropane compound represented by the following formula (A) or a pharmaceutically acceptable salt thereof has orexin receptor antagonism, and therefore has a potencial of usefulness for the treatment of sleep disorder for which orexin receptor antagonism is effective, for example, insomnia: wherein Q represents -CH- or a nitrogen atom, R 1a and R 1b each independently represent a C 1-6 alkyl group and the like, R 1c represents a hydrogen atom and the like, R 2a , R 2b , R 2c and R 2d each independently represent a hydrogen atom, a halogen atom, a C 1-6 alkyl group and the like, R 3a , R 3b and R 3c each independently represent a hydrogen atom, a halogen atom and the like, and R 3d represents a hydrogen atom and the like.</p>
申请公布号 EP2626350(A1) 申请公布日期 2013.08.14
申请号 EP20110826816 申请日期 2011.09.20
申请人 EISAI R&D MANAGEMENT CO., LTD. 发明人 TERAUCHI TARO;TAKEMURA AYUMI;DOKO TAKASHI;YOSHIDA YU;TANAKA TOSHIAKI;SORIMACHI KEIICHI;NAOE YOSHIMITSU;BEUCKMANN CARSTEN;KAZUTA YUJI
分类号 C07D401/12;A61K31/505;A61K31/506;A61K31/517;A61K31/538;A61P1/14;A61P3/10;A61P11/00;A61P13/08;A61P25/00;A61P25/04;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/34;A61P25/36;C07D239/34 主分类号 C07D401/12
代理机构 代理人
主权项
地址